UK coronavirus vaccine prompts immune response in early test

14 Sept 01:39 Key points summarised by AI

Oxford University's experimental coronavirus vaccine successfully triggered a dual immune response, producing both neutralizing antibodies and T-cells, in early human trials.
The vaccine demonstrated a protective immune response lasting at least two months in adults aged 18-55, with only minor side effects like fever and muscle pain reported.
Larger global trials are actively underway to confirm the vaccine's effectiveness, with researchers estimating potential immunization for high-risk groups in Britain by December.
Oxford has partnered with AstraZeneca to produce 2 billion doses globally, highlighting the critical need for widespread vaccination to combat the pandemic.

Flooding persists in Bangkok and 22 provinces

Today 16:00 Key points summarised by AI

Persistent flooding continues across Bangkok and 22 Thai provinces, though water levels are gradually receding in many affected areas.
Over 604,000 families, impacting approximately 1.83 million people, are still grappling with the widespread flood conditions.
The national flood death toll has reached 80 since mid-September, with fatalities reported across various provinces.
Major regions like Pathum Thani, Ayutthaya, and Bangkok report significant numbers of affected households, with hundreds of thousands still in trouble.